Advances in the diagnosis and treatment of hepatocellular carcinoma with contrast-enhanced ultrasound / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 425-429, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-954300
ABSTRACT
Hepatocellular carcinoma (HCC) is a highly prevalent tumor in China. It has an insidious onset, rapid progression, early recurrence and poor prognosis. Most patients are already in the middle and late stages when they are diagnosed and lose the best time for surgery. Therefore, early diagnosis and treatment of HCC is crucial for patients. In recent years, contrast-enhanced ultrasound (CEUS) technology has been widely used in the diagnosis of liver diseases, especially in the diagnosis and treatment of HCC, which has an irreplaceable role. Meanwhile, the image fusion technology developed on the basis of CEUS can highlight the value of CEUS in the diagnosis and treatment of HCC.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS